Under the Communiqué no. 2024-32/70 published in the Official Gazette dated 8 October 2024, Turkish-resident and approved institutions that are appointed pursuant to the Regulation on Medical Devices and the Regulation on Medical Devices for In-Vitro Diagnostic Purposes (Rep. OG: 02.06.2021) have been allowed to draw up service contracts concluded with manufacturer companies within the scope of the aforementioned regulations and the business contracts concluded with Turkish-resident persons, in foreign currency or indexed to foreign currency.
The Communiqué became effective on the date of its publication.
Our explanations provided above include general information on the issue. No responsibility can be claimed against EY and/or Kuzey YMM ve Bağımsız Denetim A.Ş. due to the implications arising from the context of this document or emerging with respect to its context.
This website uses cookies in order to ensure functionality and develop your online experience. You consent to using of cookies as included under EY Cookie Policy and Clarification Text through using this website.
Print 
Download File 
Go to Top 
